Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WindRose Analytica was a Camarillo, California-based biotech and biopharma analytics company that provided analytical and consulting services to the life sciences industry rather than developing its own therapeutic pipeline. Contemporary reporting indicates the company was launched in 2005 by former Amgen employee Alan Herman and positioned as a biotech and biopharma analytics firm. Available public sources suggest the company was acquired around 2009 by Althea, a San Diego biologics and pharmaceutical services company, and it does not appear to operate today as an independent active business. Public evidence for a proprietary drug pipeline, clinical-stage assets, or therapeutic programs is limited or absent. The company appears best characterized as a specialized life sciences analytics/services business with historical relevance in the biotech services ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WindRose Analytica.